Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Investors Business Daily
Investors Business Daily
Business
MATTHEW GALGANI

Breakout Watch: No. 1 Industry Leader Eyes Buy Point With Earnings Due

As industry peer International Money Express, or Intermex, hits new highs, Encore Capital takes aim at new buy point. ECPG stock joins financial powerhouse Visa on the IBD Breakout Stocks Index.

With a 98 Composite Rating, Encore Capital ranks No. 1 in the specialty financial services industry group. Intermex ranks a close second with a 97 rating in Stock Checkup.

Showing signs of demand, Encore Capital sports a B+ Accumulation/Distribution Rating and a 1.8 up/down volume ratio. Plus, the stock has posted three quarters of rising fund ownership, and 64 funds with an A+ or A rating from IBD own shares.

Track Upcoming Earnings Reports With This Earnings Calendar

Encore Capital Faces Earnings Test After 115% Growth

Headquartered in San Diego, Encore Capital is an international provider of debt recovery solutions and related services. Through its subsidiaries around the globe, Encore purchases or services portfolios of receivables from major banks, credit unions and utility providers.

The debt recovery solutions specialist has three primary business units: Midland Credit Management in the U.S.,  Cabot Credit Management in Europe, and LAAP, which serves the Latin America and Asia-Pacific markets. Together, the Encore Capital Group has roughly 6,600 employees with operations in nine countries.

On May 4, Encore reported 115% earnings growth, marking a third straight quarter of acceleration. Sales growth rose from a 7% slowdown in Q4 2021 to a 20% increase in the first quarter of the year.

Encore Capital is set to report Q2 earnings on Aug. 3. Analysts expect earnings to slow by 34% for the quarter, but they're forecasting 14% growth for the year.

IBD 50 stock Intermex, featured on June 28, is on tap to report Q2 earnings the same day. Wall Street consensus estimates call for 13% EPS growth in Q2 and a 12% gain for the year.

See All The Names On The IBD Breakout Stocks Index

Encore Capital Shows Strength Ahead Of Q2 Earnings

While it's risky to buy any stock just before it reports, Encore Capital continues to climb, with its relative strength line already hitting a new high.

The stock's 50-day moving average is close to retaking its longer-term 200-day line. In a sign of rebounding strength, Encore's 21-day moving average has already moved well above its 50-day and 200-day benchmarks.

After jumping nearly 5% in volume 115% higher than normal Tuesday, Encore Capital closed the session just 2% below the 72.77 buy point in a cup pattern.

With earnings also due on Aug. 3, Intermex is slightly extended beyond an earlier breakout from a double bottom, a common chart pattern in volatile markets.

See how Encore Capital and Intermex report next week — and how Wall Street reacts.

IBD Breakout Opportunities ETF

The IBD Breakout Opportunities ETF from Innovator Capital Management tracks the IBD Breakout Stocks Index. As with other index ETFs, this fund allows you to essentially invest in the entire index in addition to or rather than buying the individual stocks. Learn more here about the ETF and Innovator funds.

Follow Matthew Galgani on Twitter at @IBD_MGalgani.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.